Ginkgo commits $25M of free access to our platform for partner COVID-19 projects

Ginko is offering $25M of no-cost foundry work towards projects that can use Ginkgo’s platform to accelerate development of point of care diagnostics, vaccines, or therapeutics. If you are currently a company or academic lab that is developing a diagnostic, drug, or vaccine and are interested in leveraging Ginkgo’s infrastructure at no cost please email us at covid-response@ginkgobioworks.com.

More information.